Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04693364 · ClinicalTrials.gov registry record
Acceptability of 3D Printed Breast Models as Surgical Decision Aids for Breast Cancer Treatment
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 30
- Enrollment target
NCT04693364: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT04693364 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04693364 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study is to find out the acceptability of a 3D printed breast model by patients as they consider their surgical treatment options. Researchers also want to learn the possible impact of the 3D printed breast model in the patient's decision making process.
Primary Outcome
Will be assessed based on changes in decisional conflict scale data collected before and after use of the 3 dimensional (3D) printed breast model during consultation with the breast surgeon using paired sample t-tests.
Interventions
- OTHER Questionnaire Administration
- PROCEDURE Discussion
- OTHER Decision Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-12-27 |
| Est. Completion | 2022-02-22 |
What the finished NCT04693364 record still lists
NCT04693364 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT04693364 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04693364 about?
NCT04693364 is a clinical study titled "Acceptability of 3D Printed Breast Models as Surgical Decision Aids for Breast Cancer Treatment". This study is to find out the acceptability of a 3D printed breast model by patients as they consider their surgical treatment options. Researchers also want to learn the possible impact of the 3D printed breast model in the patient's decision making process.
What is the current status of trial NCT04693364?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2017-12-27. Estimated completion is 2022-02-22.
What interventions are being tested in trial NCT04693364?
The interventions under investigation include: Questionnaire Administration (OTHER), Discussion (PROCEDURE), Decision Aid (OTHER).
Who is sponsoring clinical trial NCT04693364?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI